Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of human lung cancer patients with sqamous cell or adenocarcinoma at different stages of disease to identify gene signatures to predict prognosis


ABSTRACT: Gene signatures were derived to separate high risk patients from low risk ones. Experiment Overall Design: 130 samples from 129 patients

ORGANISM(S): Homo sapiens

SUBMITTER: Jack Yu 

PROVIDER: E-GEOD-4573 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

Raponi Mitch M   Zhang Yi Y   Yu Jack J   Chen Guoan G   Lee Grace G   Taylor Jeremy M G JM   Macdonald James J   Thomas Dafydd D   Moskaluk Christopher C   Wang Yixin Y   Beer David G DG  

Cancer research 20060801 15


Non-small-cell lung cancers (NSCLC) compose 80% of all lung carcinomas with squamous cell carcinomas (SCC) and adenocarcinoma representing the majority of these tumors. Although patients with early-stage NSCLC typically have a better outcome, 35% to 50% will relapse within 5 years after surgical treatment. We have profiled primary squamous cell lung carcinomas from 129 patients using Affymetrix U133A gene chips. Unsupervised analysis revealed two clusters of SCC that had no correlation with tumo  ...[more]

Similar Datasets

2006-03-30 | GSE4573 | GEO
2020-12-31 | E-MTAB-8588 | biostudies-arrayexpress
2022-02-11 | E-MTAB-8801 | biostudies-arrayexpress
2023-12-21 | GSE190271 | GEO
2014-09-30 | E-GEOD-56532 | biostudies-arrayexpress
2016-01-13 | E-GEOD-76775 | biostudies-arrayexpress
2020-09-10 | PXD020078 | Pride
2018-09-28 | E-MTAB-6448 | biostudies-arrayexpress
2023-09-20 | PXD027715 | Pride
2016-01-13 | GSE76775 | GEO